MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Depression"

  • 2016 International Congress

    Clinical correlates of depression and anxiety in patients with Parkinson’s disease

    H.D. Hambardzumyan, H.M. Manvelyan (Yerevan, Armenia)

    Objective: To clarify whether depression and anxiety are similar in terms of their associations with other clinical variables. Background: Although depression and anxiety are important…
  • 2016 International Congress

    Depression and clinical progression in spinocerebellar ataxias

    S.H. Kuo, R.Y. Lo, K.P. Figueroa, S.M. Pulst, S. Perlman, G. Wilmot, C. Gomez, J. Schmahmann, H. Paulson, V.G. Shakkottai, S. Ying, T. Zesiewicz, K. Bushara, M. Geschwind, G. Xia, T. Ashizawa, S.H. Subramony (New York, NY, USA)

    Objective: To study the prevalence and influence of depressive symptoms in spinocerebellar ataxias (SCAs). Background: Depression is a common comorbidity in SCAs but its association…
  • 2016 International Congress

    Yearly four months’ disability gap in cervical dystonia due to run-out botulinum toxin effect

    K.K. Martikainen, S. Kinos, R.J. Marttila (Turku, Finland)

    Objective: To investigate the causes of disability in patients with cervical dystonia. Background: Despite the development of medical treatment, cervical dystonia impairs the daily living…
  • 2016 International Congress

    The non-motor side of the honey-moon period of Parkinson’s disease

    R. Erro, M. Picillo, C. Vitale, M. Amboni, M. Moccia, M.T. Pellecchia, P. Barone (London, United Kingdom)

    Objective: To explore the non-motor side of the honey-moon period in Parkinson's disease (PD) and its impact on quality of life (QoL). Background: Although there…
  • 2016 International Congress

    Suicide attempts and Huntington’s disease: Perseveration, not just impulsivity

    O.C. Roman, J.G. Stovall, D.O. Claassen (Nashville, TN, USA)

    Objective: To present the hypothesis that perseveration, not just impulsivity, is a risk factor for suicide attempts in Huntington's disease (HD). Background: The elevated incidence…
  • 2016 International Congress

    Cervical dystonia and quality of life

    S. Tomic, I. Petkovic, T. Pucic, S. Juric, S. Butkovic Soldo (Osijek, Croatia)

    Objective: To evaluate appearance of depression and anxiety in patiens with cervical dystonia and influence of dystonia symptoms on the quality of life. Background: Cervical…
  • 2016 International Congress

    Associated and predictive factors of depressive symptoms in patients with Parkinson’s disease

    K. Zhu, J.J. Van Hilten, J. Marinus (Leiden, Netherlands)

    Objective: The aim of this longitudinal study is to examine which variables are associated with depressive symptoms in Parkinson's disease (PD), as well as to…
  • 2016 International Congress

    Clinical and neuroimaging correlations in early manifest Huntington’s disease patients: Default mode network properties according to resting-state functional MRI

    Y.A. Seliverstov, E.V. Seliverstova, S.A. Klyushnikov, R.N. Konovalov, S.N. Illarioshkin (Moscow, Russia)

    Objective: (1) To compare pattern of spontaneous activity within default mode network (DMN) between early manifest Huntington's disease (HD) patients and healthy controls and (2)…
  • 2016 International Congress

    Clinical characteristics and natural history of oromandibular dystonia

    L. Scorr, S. Factor, H. Jinnah (Atlanta, GA, USA)

    Objective: The overall goal of this study is to better define the clinical characteristics and natural history of oromandibular dystonia (OMD). Background: OMD is a…
  • 2016 International Congress

    Non motor symptoms burden and motor staging of Parkinson’s disease: Evidence for dichotomy and non-motor dominant subtypes from analysis of 249 cases

    K. Ray Chaudhuri, A. Sauerbier, T. Thavayogarajah, A. Rizos, L. Perkins, C. Rodriguez Blazquez, P. Martinez-Martin, On behalf of EUROPAR, the MDS Non-Motor PD Study Group, The NILS Group (London, United Kingdom)

    Objective: To address the co-occurrence of the burden of non-motor symptoms staging (NMSB) and motor severity of Parkinson's disease (PD) using the Hoehn and Yahr…
  • « Previous Page
  • 1
  • …
  • 32
  • 33
  • 34
  • 35
  • 36
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley